Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-05-18 @ 3:03 AM
Study NCT ID:
NCT01848756
Status:
TERMINATED
Last Update Posted:
2017-02-09
First Post:
2013-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
Sponsor:
Esanex Inc.
Organization: